SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-037987
Filing Date
2023-06-16
Accepted
2023-06-16 17:09:38
Documents
1
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4099
  Complete submission text file 0001209191-23-037987.txt   5531
Mailing Address C/O LUMENA PHARMACEUTICALS, INC. 12531 HIGH BLUFF DRIVE, SUITE 110 SAN DIEGO CA 92130
Business Address
McNulty Alana B. (Reporting) CIK: 0001606086 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 231022204

Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations